Inactive Instrument

Invuity Inc

US46187J2050

Medical Equipment, Supplies & Distribution

Invuity, Inc.(NasdaqGM:IVTY) dropped from NASDAQ Composite Index

October 23, 2018 at 12:00 am EDT

Invuity, Inc. has been removed from NASDAQ Composite Index .

Latest news about Invuity Inc

Invuity, Inc.(NasdaqGM:IVTY) dropped from S&P TMI Index	18-10-24	CI
Invuity, Inc.(NasdaqGM:IVTY) dropped from S&P Global BMI Index	18-10-24	CI
Invuity, Inc. Announces Board Changes	18-10-23	CI
Invuity, Inc.(NasdaqGM:IVTY) dropped from NASDAQ Composite Index	18-10-23	CI
Stryker Corporation completed the acquisition of Invuity, Inc..	18-10-21	CI
Stryker Corporation entered into an agreement and plan of merger to acquire Invuity, Inc. for approximately $180 million.	18-09-10	CI
Invuity Announces Commercial Launch of PhotonGuide® Adapt for Vaginal Hysterectomy and Pelvic Organ Prolapse Procedures	18-08-14	CI
Invuity, Inc., Q2 2018 Earnings Call, Aug 02, 2018	18-08-02
Invuity, Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2018; Provides Revenue Guidance for the Year 2018	18-08-02	CI
Certain Common Stock of Invuity, Inc. are subject to a Lock-Up Agreement Ending on 13-JUN-2018.	18-06-12	CI
Certain Stock Options of Invuity, Inc. are subject to a Lock-Up Agreement Ending on 13-JUN-2018.	18-06-12	CI
Certain Restricted Stock Units of Invuity, Inc. are subject to a Lock-Up Agreement Ending on 13-JUN-2018.	18-06-12	CI
Certain Warrants of Invuity, Inc. are subject to a Lock-Up Agreement Ending on 13-JUN-2018.	18-06-12	CI
Invuity, Inc., Q1 2018 Earnings Call, May 03, 2018	18-05-03
Invuity, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2018; Reaffirms Earnings Guidance for 2018	18-05-02	CI
Invuity, Inc. Auditor Raises 'Going Concern' Doubt	18-03-04	CI
Invuity, Inc Announces Executive Changes	18-02-28	CI
Invuity, Inc., Q4 2017 Earnings Call, Feb 13, 2018	18-02-13
Invuity, Inc. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Year Ended Dec. 31, 2017; Provides Revenue Guidance for the First Quarter and Full Year 2018	18-02-13	CI
Invuity, Inc. Appoints Scott D. Flora as Board of Directors	17-11-21	CI
Invuity, Inc., Q3 2017 Earnings Call, Nov 07, 2017	17-11-07
Invuity, Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended Sept. 30, 2017; Provides Revenue Guidance for the Year 2017	17-11-07	CI
Invuity, Inc. Strengthens Senior Management with Appointment of Marcia Fish as Chief Human Resources Officer	17-10-17	CI
Invuity, Inc. Draws $10 Million Second Tranche of Term Loan	17-09-27	CI
Invuity Announces Full Commercial Launch of PhotonBlade™	17-09-25	CI

Invuity, Inc. is a United States-based medical technology company. The Company is focused on developing and marketing photonics devices to improve the ability of surgeons to illuminate and visualize the surgical cavity during open minimally invasive and minimal access surgery. Its Photonics technology is integrated into a family of optical waveguides, including its line of reusable tissue retractors, single-use handheld aspiration and universal drop-in intracavity illuminator devices. Its Photonics technology converts thermally hot, concentrated light output to thermally cool volumetric illumination throughout the entire surgical cavity. Its products include Eikon, Eika, Eipex, Eivector, Breiten, Saber Yankauer, PhotonSaber F and Waveguide XT. Its clinical applications include women's health, encompassing breast cancer and breast reconstructive surgery, and thyroid surgery. Its additional applications include procedures for electrophysiology, cardiothoracic and general surgery.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Invuity Inc

Equities

US46187J2050

Medical Equipment, Supplies & Distribution

Invuity, Inc.(NasdaqGM:IVTY) dropped from NASDAQ Composite Index

Latest news about Invuity Inc

Chart Invuity Inc

Company Profile